Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers November 18, 2017
Pharmacy Choice - Pharmaceutical News - Sarepta soars on positive results from early-stage DMD clinical trial [Tehran Times (Iran)] - November 18, 2017

Pharmacy News Article

 9/7/17 - Sarepta soars on positive results from early-stage DMD clinical trial [Tehran Times (Iran)]

Shares in Sarepta Therapeutics Inc (NASDAQ:SRPT) surged in pre-market trade on Wednesday after the drug developer reported successful results from an early stage trial of its Duchenne muscular dystrophy treatment.

Sarepta said the phase I/II study of Golodirsen met all primary and secondary endpoints.

DMD is a rare progressive disease muscle disease found only in young boys who lack the protein dystrophin which is critical to muscle function.

All of the 25 boys who took part in the European trial responded to the treatment which Sarepta said demonstrated proof of mechanism.

On average, the levels of dystrophin in each patient increased almost eleven-fold from baseline.

Sarepta already has a drug that received accelerated approval from the FDA last year and is approved for treatment in patients who have a confirmed mutation in the DMD gene that is amenable to exon 51 skipping.

That accounts for around 13% of the DMD market. Golodirsen is testing patients who have a confirmed mutation in the DMD gene that is amenable to exon 51 skipping, which accounts for around 8% of patients.

This is now the second exon-skipping agent to have shown a statistically significant increase in dystrophin production, validating the exon-skipping approach to treating DMD boys with amenable mutations, said principal investigator Francesco Muntoni.

Sarepta shares added 14.3% tin pre-market trading to US$46.94. In the reguklar session they added over 11% to $45.61 each.



(c) 2017 TehranTimes. All Rights Reserved. Provided by SyndiGate Media Inc. (Syndigate.info).

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
Nov 19: Biosimilar Drugs: Legal, Regulatory & Safety Considerations
Nov 20: Obesity Management: Overview of Pharmacotherapy
Nov 21: Standards of Practice for Filling Controlled Substance Prescriptions in Florida
Nov 22: Medical Marijuana: Examining the Science, Not the Politics
Nov 27: Drug Diversion and the Law: Updates and Considerations
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415